These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29547009)

  • 1. Contributions of BMPR2 Mutations and Extrinsic Factors to Cellular Phenotypes of Pulmonary Arterial Hypertension Revealed by Induced Pluripotent Stem Cell Modeling.
    Kiskin FN; Chang CH; Huang CJZ; Kwieder B; Cheung C; Dunmore BJ; Serrano F; Sinha S; Morrell NW; Rana AA
    Am J Respir Crit Care Med; 2018 Jul; 198(2):271-275. PubMed ID: 29547009
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.
    Navas P; Tenorio J; Quezada CA; Barrios E; Gordo G; Arias P; López Meseguer M; Santos-Lozano A; Palomino Doza J; Lapunzina P; Escribano Subías P
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1011-1019. PubMed ID: 27453251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
    Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
    J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.
    Zhu N; Gonzaga-Jauregui C; Welch CL; Ma L; Qi H; King AK; Krishnan U; Rosenzweig EB; Ivy DD; Austin ED; Hamid R; Nichols WC; Pauciulo MW; Lutz KA; Sawle A; Reid JG; Overton JD; Baras A; Dewey F; Shen Y; Chung WK
    Circ Genom Precis Med; 2018 Apr; 11(4):e001887. PubMed ID: 29631995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-BMPR2 mutation heritable pulmonary arterial hypertension in Southeast Asia.
    Pussadhamma B; Kiatchoosakun S; Vannaprasaht S; Barozzi C
    Asian Cardiovasc Thorac Ann; 2015 May; 23(4):481-3. PubMed ID: 24948783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
    Evans JD; Girerd B; Montani D; Wang XJ; Galiè N; Austin ED; Elliott G; Asano K; Grünig E; Yan Y; Jing ZC; Manes A; Palazzini M; Wheeler LA; Nakayama I; Satoh T; Eichstaedt C; Hinderhofer K; Wolf M; Rosenzweig EB; Chung WK; Soubrier F; Simonneau G; Sitbon O; Gräf S; Kaptoge S; Di Angelantonio E; Humbert M; Morrell NW
    Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A; Kizhakkedath P; Al-Gazali L; Ali BR
    Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-frame deletion in exon 3 and a missense mutation in exon 11 of the BMPR2 gene.
    Usman A; Haase A; Merkert S; Göhring G; Hansmann G; Gall H; Schermuly R; Martin U; Olmer R
    Stem Cell Res; 2021 Aug; 55():102488. PubMed ID: 34388490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Rhodes CJ; Im H; Cao A; Hennigs JK; Wang L; Sa S; Chen PI; Nickel NP; Miyagawa K; Hopper RK; Tojais NF; Li CG; Gu M; Spiekerkoetter E; Xian Z; Chen R; Zhao M; Kaschwich M; Del Rosario PA; Bernstein D; Zamanian RT; Wu JC; Snyder MP; Rabinovitch M
    Am J Respir Crit Care Med; 2015 Aug; 192(3):356-66. PubMed ID: 26030479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo mutations in the BMPR2 gene in patients with heritable pulmonary arterial hypertension.
    Momose Y; Aimi Y; Hirayama T; Kataoka M; Ono M; Yoshino H; Satoh T; Gamou S
    Ann Hum Genet; 2015 Mar; 79(2):85-91. PubMed ID: 25612240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.
    Ghigna MR; Guignabert C; Montani D; Girerd B; Jaïs X; Savale L; Hervé P; Thomas de Montpréville V; Mercier O; Sitbon O; Soubrier F; Fadel E; Simonneau G; Humbert M; Dorfmüller P
    Eur Respir J; 2016 Dec; 48(6):1668-1681. PubMed ID: 27811071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.
    Schwiening M; Swietlik EM; Pandya D; Burling K; Barker P; Feng OY; Treacy CM; Abreu S; Wort SJ; Pepke-Zaba J; Graf S; Marciniak SJ; Morrell NW; Soon E
    Chest; 2022 Jun; 161(6):1651-1656. PubMed ID: 35063447
    [No Abstract]   [Full Text] [Related]  

  • 14. Heritable pulmonary hypertension: from bench to bedside.
    Girerd B; Weatherald J; Montani D; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years.
    Hinderhofer K; Fischer C; Pfarr N; Szamalek-Hoegel J; Lichtblau M; Nagel C; Egenlauf B; Ehlken N; Grünig E
    PLoS One; 2014; 9(3):e91374. PubMed ID: 24621962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension.
    Braam EA; Quanjel MJ; Van Haren-Willems JH; Van Oosterhout MF; Vink A; Heijdra YF; Kwakkel-van Erp JM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):182-5. PubMed ID: 27537724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
    Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
    Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
    Kabata H; Satoh T; Kataoka M; Tamura Y; Ono T; Yamamoto M; Huqun ; Hagiwara K; Fukuda K; Betsuyaku T; Asano K
    Respirology; 2013 Oct; 18(7):1076-82. PubMed ID: 23675998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of pulmonary arterial hypertension and straight back syndrome in a patient with a novel BMPR2 variant affecting cytoplasmic tail domain.
    Tang M; Luo J; Liu Q; Song J
    Eur J Med Res; 2024 Apr; 29(1):209. PubMed ID: 38561801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases.
    Eyries M; Montani D; Nadaud S; Girerd B; Levy M; Bourdin A; Trésorier R; Chaouat A; Cottin V; Sanfiorenzo C; Prevot G; Reynaud-Gaubert M; Dromer C; Houeijeh A; Nguyen K; Coulet F; Bonnet D; Humbert M; Soubrier F
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30578383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.